Drugmaker Corcept seeks to bar ex — judge's views in Teva antitrust case

By Mike Scarcella WASHINGTON, Oct 12 (Reuters) — Drugmaker Corcept Therapeutics is seeking to exclude testimony from a retired federal appeals court judge supporting Teva Pharmaceuticals in an antitrust lawsuit, arguing her opinions could sway jurors without shedding light on the facts of the case. In a filing on Friday in federal court in California, Corcept said consultant and retired judge Kathleen O’Malley of the US Court of Appeals for the Federal Circuit offered no technical expertise and that her presentation of legal opinions was inappropriate. "Judge O’Malley’s usurpation of the jury is particularly harmful given her position as a former jurist," Corcept said. "It is likely that the jury will not understand she brings no technical expertise in any factual area in the case and give her testimony undue weight, even though her opinions are ultimately just how she thinks the jury should decide." Teva, Corcept and O’Malley did not immediately respond to requests for comment. Teva sued Corcept in 2024, claiming it monopolized the market for the drug Korlym to treat the hormonal disorder Cushing's syndrome. The lawsuit said Teva suffered "substantial lost revenue" from its effort